vs

Side-by-side financial comparison of OPTICAL CABLE CORP (OCC) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

OPTICAL CABLE CORP is the larger business by last-quarter revenue ($19.8M vs $17.6M, roughly 1.1× AVITA Medical, Inc.). OPTICAL CABLE CORP runs the higher net margin — 0.2% vs -66.0%, a 66.2% gap on every dollar of revenue. On growth, OPTICAL CABLE CORP posted the faster year-over-year revenue change (1.8% vs -4.3%). OPTICAL CABLE CORP produced more free cash flow last quarter ($718.8K vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 15.5%).

Optical Cable Corporation, headquartered in Roanoke, Virginia, manufactures fiber optical cable. The company's cable is largely used for telecommunications and is sold both in the US and seventy other countries worldwide. OCC also manufactures military land tactical fiber optic cable for the U.S. military.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

OCC vs RCEL — Head-to-Head

Bigger by revenue
OCC
OCC
1.1× larger
OCC
$19.8M
$17.6M
RCEL
Growing faster (revenue YoY)
OCC
OCC
+6.1% gap
OCC
1.8%
-4.3%
RCEL
Higher net margin
OCC
OCC
66.2% more per $
OCC
0.2%
-66.0%
RCEL
More free cash flow
OCC
OCC
$6.8M more FCF
OCC
$718.8K
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
15.5%
OCC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCC
OCC
RCEL
RCEL
Revenue
$19.8M
$17.6M
Net Profit
$48.6K
$-11.6M
Gross Margin
31.9%
81.2%
Operating Margin
1.4%
-59.1%
Net Margin
0.2%
-66.0%
Revenue YoY
1.8%
-4.3%
Net Profit YoY
-87.0%
-0.3%
EPS (diluted)
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCC
OCC
RCEL
RCEL
Q4 25
$19.8M
$17.6M
Q3 25
$19.9M
$17.1M
Q2 25
$17.5M
$18.4M
Q1 25
$15.7M
$18.5M
Q4 24
$19.5M
$18.4M
Q3 24
$16.2M
$19.5M
Q2 24
$16.1M
$15.2M
Q1 24
$14.9M
$11.1M
Net Profit
OCC
OCC
RCEL
RCEL
Q4 25
$48.6K
$-11.6M
Q3 25
$301.9K
$-13.2M
Q2 25
$-697.9K
$-9.9M
Q1 25
$-1.1M
$-13.9M
Q4 24
$373.5K
$-11.6M
Q3 24
$-1.6M
$-16.2M
Q2 24
$-1.6M
$-15.4M
Q1 24
$-1.4M
$-18.7M
Gross Margin
OCC
OCC
RCEL
RCEL
Q4 25
31.9%
81.2%
Q3 25
31.7%
81.3%
Q2 25
30.4%
81.2%
Q1 25
29.4%
84.7%
Q4 24
33.5%
87.6%
Q3 24
24.2%
83.7%
Q2 24
25.1%
86.1%
Q1 24
25.0%
86.4%
Operating Margin
OCC
OCC
RCEL
RCEL
Q4 25
1.4%
-59.1%
Q3 25
2.8%
-53.6%
Q2 25
-2.4%
-60.5%
Q1 25
-5.4%
-63.9%
Q4 24
3.4%
-54.1%
Q3 24
-8.2%
-70.6%
Q2 24
-8.1%
-102.8%
Q1 24
-9.4%
-155.0%
Net Margin
OCC
OCC
RCEL
RCEL
Q4 25
0.2%
-66.0%
Q3 25
1.5%
-77.3%
Q2 25
-4.0%
-53.9%
Q1 25
-7.0%
-74.9%
Q4 24
1.9%
-63.0%
Q3 24
-9.6%
-82.9%
Q2 24
-9.9%
-101.3%
Q1 24
-9.6%
-168.0%
EPS (diluted)
OCC
OCC
RCEL
RCEL
Q4 25
$-0.37
Q3 25
$-0.46
Q2 25
$-0.38
Q1 25
$-0.53
Q4 24
$-0.44
Q3 24
$-0.62
Q2 24
$-0.60
Q1 24
$-0.18
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCC
OCC
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$237.5K
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$16.5M
$-16.6M
Total Assets
$40.1M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCC
OCC
RCEL
RCEL
Q4 25
$237.5K
$18.2M
Q3 25
$421.4K
$23.3M
Q2 25
$894.3K
$15.7M
Q1 25
$128.3K
$25.8M
Q4 24
$244.2K
$35.9M
Q3 24
$796.7K
$44.4M
Q2 24
$1.1M
$54.1M
Q1 24
$221.0K
$68.2M
Stockholders' Equity
OCC
OCC
RCEL
RCEL
Q4 25
$16.5M
$-16.6M
Q3 25
$18.2M
$-6.7M
Q2 25
$19.1M
$-12.9M
Q1 25
$19.7M
$-4.6M
Q4 24
$20.8M
$4.5M
Q3 24
$20.4M
$12.2M
Q2 24
$21.8M
$23.9M
Q1 24
$23.3M
$32.6M
Total Assets
OCC
OCC
RCEL
RCEL
Q4 25
$40.1M
$56.4M
Q3 25
$40.2M
$63.7M
Q2 25
$39.1M
$58.1M
Q1 25
$37.8M
$69.6M
Q4 24
$40.4M
$79.7M
Q3 24
$37.6M
$81.1M
Q2 24
$39.9M
$87.8M
Q1 24
$40.5M
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCC
OCC
RCEL
RCEL
Operating Cash FlowLast quarter
$797.3K
$-5.4M
Free Cash FlowOCF − Capex
$718.8K
$-6.1M
FCF MarginFCF / Revenue
3.6%
-34.7%
Capex IntensityCapex / Revenue
0.4%
3.8%
Cash ConversionOCF / Net Profit
16.40×
TTM Free Cash FlowTrailing 4 quarters
$1.1M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCC
OCC
RCEL
RCEL
Q4 25
$797.3K
$-5.4M
Q3 25
$-2.2M
$-5.2M
Q2 25
$141.4K
$-10.2M
Q1 25
$2.7M
$-10.3M
Q4 24
$-1.5M
$-8.1M
Q3 24
$552.4K
$-7.2M
Q2 24
$373.7K
$-12.8M
Q1 24
$-261.1K
$-20.9M
Free Cash Flow
OCC
OCC
RCEL
RCEL
Q4 25
$718.8K
$-6.1M
Q3 25
$-2.3M
$-6.2M
Q2 25
$73.4K
$-10.8M
Q1 25
$2.6M
$-10.5M
Q4 24
$-1.6M
$-9.7M
Q3 24
$475.2K
$-11.0M
Q2 24
$218.2K
$-15.4M
Q1 24
$-341.5K
$-22.0M
FCF Margin
OCC
OCC
RCEL
RCEL
Q4 25
3.6%
-34.7%
Q3 25
-11.4%
-36.1%
Q2 25
0.4%
-58.4%
Q1 25
16.5%
-56.9%
Q4 24
-8.1%
-52.7%
Q3 24
2.9%
-56.1%
Q2 24
1.4%
-101.6%
Q1 24
-2.3%
-198.2%
Capex Intensity
OCC
OCC
RCEL
RCEL
Q4 25
0.4%
3.8%
Q3 25
0.4%
5.5%
Q2 25
0.4%
2.8%
Q1 25
0.5%
1.2%
Q4 24
0.3%
8.8%
Q3 24
0.5%
19.2%
Q2 24
1.0%
17.5%
Q1 24
0.5%
10.3%
Cash Conversion
OCC
OCC
RCEL
RCEL
Q4 25
16.40×
Q3 25
-7.29×
Q2 25
Q1 25
Q4 24
-4.08×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons